340B Drug Pricing Program
Please encourage your House representatives to co-sponsor the 340B Rebate Model Delay Act (H.R. 10770), a bipartisan bill that would pause the Department of Health and Human Services 340B Rebate Model Pilot Program, currently set to go into effect Jan. 1, 2027.
AHA urges court to reject drug industry intervention in 340B rebate program case.
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to intervene in the lawsuit challenging the administration’s revised 340B rebate model, the AHA and its co-plaintiffs argued in a filing submitted…
The AHA today voiced support () for the 340B Rebate Model Delay Act (H.R. 10770)in a letter to the bill’s House sponsors. The bipartisan bill would pause the Department of Health and Human Services’ 340B Rebate Model Pilot Program, currently set to go into effect Jan. 1, 2027.
The AHA today voiced support for the 340B Rebate Model Delay Act (H.R. 10770) in a letter to the bill’s House sponsors.
The American Hospital Association voices support of the 340B Rebate Model Delay Act (H.R. 10770).
The AHA, the Maine Hospital Association and four safety-net hospitals Oct. 9 filed a lawsuit in the U.S. District Court for the District of Maine challenging changes by the Department of Health and Human Services to the 340B Drug Pricing Program that would expand the use of a proposed rebate model…
AHA, MHA, and four safety-net hospitals filed a motion for a temporary restraining order to stop the costly 340B rebate program that will force hospitals providing care to America’s most vulnerable patients to spend billions on administrative costs.
The AHA, the Maine Hospital Association and four safety-net hospitals today filed a lawsuit in the U.S. District Court for the District of Maine challenging changes by the HHS to the 340B Drug Pricing Program that would expand the use of a proposed rebate model previously halted by the courts.
The revised 340B rebate program will force hospitals providing care to America’s most vulnerable patients to spend billions on administrative costs, repeating the same flaws courts previously identified.